Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Cost of Revenue

$8.23B

TTM · Period ending: Jun 30, 2026 · USD

TEVA Cost of Revenue

Latest reported$8.23Bperiod endingJun 30, 2026

Latest reported$8.23Bperiod endingJun 30, 2026

TEVA TTM Cost of Revenue ($0.00 → $8.23B)

TTM cost of revenue

High-resolution chart · PNG

TEVA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	1,090,328,000
Mar 31, 2001	1,032,584,000
Dec 31, 2000	938,370,000
Sep 30, 2000	879,376,000
Jun 30, 2000	802,355,000
Mar 31, 2000	724,154,000
Dec 31, 1999	699,203,000
Sep 30, 1999	661,700,000
Jun 30, 1999	655,000,000
Mar 31, 1999	640,500,000
Dec 31, 1998	636,200,000
Sep 30, 1998	514,900,000
Jun 30, 1998	328,900,000
Mar 31, 1998	170,500,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Sep 30, 1987	0
Jun 30, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.